TEST BANK FOR PHARMACOLOGY 10TH EDITION BY MCCUISTION
x x x x x x x
TESTBANK x
Table of Content
x x
1. Chapter 01: The Nursing Process and Patient-Centered Care
x x x x x x 4 x
2. Chapter 02: Drug Development and Ethical Considerations ..................................... 10
x x x x x x
3. Chapter 03: Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics ............. 18
x x x x x
4. McCuistion: Pharmacology: ...................................................................................... 18
x
5. Chapter 04: Pharmacogenetics................................................................................... 32
x x
6. Chapter 05: Complementary and Alternative Therapies ........................................... 35
x x x x x
2|Pag
x x x x
e
x
, TEST BANK FOR PHARMACOLOGY 10TH EDITION BY MCCUISTION
x x x x x x x
7. Chapter 06: Pediatric Considerations ........................................................................40
x x x
8. Chapter 07: Geriatric Considerations.........................................................................47
x x x
9. Chapter 08: Drugs of Abuse .......................................................................................53
x x x x
10. Chapter 09: Safety and Quality...............................................................................59
x x x x
11. Chapter 10: Drug Administration ...........................................................................65
x x x
12. Chapter 11: Drug Calculations ...............................................................................70
x x x
13. Chapter 12: Fluid Volume and Electrolytes ............................................................75
x x x x x
14. Chapter 13: Vitamin and Mineral Replacement ......................................................84
x x x x x
15. Chapter 14: Nutritional Support .............................................................................91
x x x
16. Chapter 15: Adrenergic Agonists and Antagonists.................................................99
x x x x x
17. Chapter 16: Cholinergic Agonists and Antagonists..............................................105
x x x x x
18. Chapter 17: Stimulants ......................................................................................... 111
x x
19. Chapter 18: Depressants ....................................................................................... 115
x x
20. Chapter 19: Antiseizure Drugs .............................................................................121
x x x
21. Chapter 20: Drugs for Parkinson Disease and Alzheimer Disease .......................128
x x x x x x x x
22. Chapter 21: Drugs for Neuromuscular Disorders and Muscle Spasms ................134
x x x x x x x x
23. Chapter 22: Antipsychotics and Anxiolytics ........................................................140
x x x x
24. Chapter 23: Antidepressants and Mood Stabilizers ..............................................147
x x x x x
25. Chapter 24: Antiinflammatories ...........................................................................154
x x
26. Chapter 25: Analgesics .........................................................................................161
x x
27. Chapter 26: Antibacterials ....................................................................................168
x x
28. Chapter 27: Antituberculars, Antifungals, and Antivirals ....................................184
x x x x x
29. Chapter 28: Peptides, Antimalarials, and Anthelmintics ......................................192
x x x x x
30. Chapter 29: HIV- and AIDS-Related Drugs.........................................................195
x x x x x
31. Chapter 30: Transplant Drugs ...............................................................................199
x x x
32. Chapter 31: Vaccines............................................................................................202
x x
33. Chapter 32: Anticancer Drugs ..............................................................................206
x x x
34. Chapter 33: Targeted Therapies to Treat Cancer...................................................210
x x x x x x
35. Chapter 34: Biologic Response Modifiers ............................................................213
x x x x
36. Chapter 35: Upper Respiratory Disorders ............................................................217
x x x x
37. Chapter 36: Lower Respiratory Disorders ............................................................221
x x x x
38. Chapter 37: Cardiac Glycosides, Antianginals, and Antidysrhythmics .................227
x x x x x x
39. Chapter 38: Diuretics............................................................................................234
x x
40. Chapter 39: Antihypertensives .............................................................................238
x x
41. Chapter 40: Anticoagulants, Antiplatelets, and Thrombolytics ............................244
x x x x x
3|Pag
x x x x
e
x
, TEST BANK FOR PHARMACOLOGY 10TH EDITION BY MCCUISTION
x x x x x x x
42. Chapter 41: Antihyperlipidemics and Peripheral Vasodilators ............................251
x x x x x
43. Chapter 42: Gastrointestinal Tract Disorders .......................................................256
x x x x
44. Chapter 43: Antiulcer Drugs ................................................................................262
x x x
45. Chapter 44: Eye and Ear Disorders.......................................................................268
x x x x x
46. Chapter 45: Dermatologic Disorders ....................................................................272
x x x
47. Chapter 46: Pituitary, Thyroid, Parathyroid, and Adrenal Disorders ...................277
x x x x x x x
48. Chapter 47: Antidiabetics .....................................................................................284
x x
49. Chapter 48: Urinary Disorders .............................................................................290
x x x
50. Chapter 49: Pregnancy and Preterm Labor ...........................................................295
x x x x x
51. Chapter 50: Labor, Delivery, and Postpartum .......................................................301
x x x x x
52. Chapter 51: Neonatal and Newborn .....................................................................306
x x x x
53. Chapter 52: Women’s Reproductive Health ..........................................................308
x x x x
54. Chapter 53: Men’s Reproductive Health ..............................................................314
x x x x
55. Chapter 54: Sexually Transmitted Infections .......................................................318
x x x x
56. Chapter 55: Adult and Pediatric Emergency Drugs..............................................321
x x x x x x
1. Chapter 01: The Nursing Process and Patient-Centered Care
x x x x x x x
x McCuistion: Pharmacology: A Patient-Centered Nursing Process Approach, 10th
x x x x x x x
x Edition
MULTIPLE CHOICE x
1. The nursing process is a five-step decision-making approach that includes all of the following
x x x x x x x x x x x x x
steps, EXCEPT:
x x
a. Assessment
b. Patient problem
x
4|Pag
x x x x
e
x
, TEST BANK FOR PHARMACOLOGY 10TH EDITION BY MCCUISTION x x x x x x x
c. Planning
d. Right Drug x
ANS: D x
The nursing process is a five-step decision-making approach that includes: 1) assessment, 2)
x x x x x x x x x x x x
patient problem, 3) planning, 4) implementation, and 5) evaluation. “Right drug” is one of the
x x x x x x x x x x x x x x x
“Six Rights” of medication administration.
x x x x x
DIF: Cognitive Level: Understanding (Comprehension) x x x TOP: Nursing Process: x x
Planning MSC: NCLEX: Management of Care
x x x x x x
2. The nurse is using data collected to set goals or expected outcomes and interventions that
x x x x x x x x x x x x x x
x address the patient’s problems. Which step of the nursing process is the nurse applying?
x x x x x x x x x x x x x
a. Assessment
b. Patient problem x
c. Planning
d. Evaluation
ANS: C x
During the planning phase, the nurse uses the data collected to set goals or expected outcomes
x x x x x x x x x x x x x x x
and interventions which address the patient’s problems. The data was collected during the
x x x x x x x x x x x x x
“Assessment” and “Patient problem” steps. During the “Evaluation” phase the nurse would
x x x x x x x x x x x x
determine whether the goals and objectives set during the planning phase were met.
x x x x x x x x x x x x x
DIF: Cognitive Level: Understanding (Comprehension) x x x
TOP: Nursing Process: Nursing Intervention
x x x x x
MSC: NCLEX: Management of Care
x x x x
3. A 5-year-old child with type 1 diabetes mellitus has had repeated hospitalizations for episodes
x x x x x x x x x x x x x
of hyperglycemia. The parents tell the nurse that they can’t keep track of everything that has
x x x x x x x x x x x x x x x x
to be done to care for their child. The nurse reviews medications, diet, and symptom
x x x x x x x x x x x x x x x
management with the parents and draws up a daily checklist for the family to use. These
x x x x x x x x x x x x x x x x
activities are completed in which step of the nursing process?
x x x x x x x x x x
a. Assessment
b. Planning
c. Implementation
d. Evaluation
ANS: C x
5|Pag x x x x
e
x
x x x x x x x
TESTBANK x
Table of Content
x x
1. Chapter 01: The Nursing Process and Patient-Centered Care
x x x x x x 4 x
2. Chapter 02: Drug Development and Ethical Considerations ..................................... 10
x x x x x x
3. Chapter 03: Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics ............. 18
x x x x x
4. McCuistion: Pharmacology: ...................................................................................... 18
x
5. Chapter 04: Pharmacogenetics................................................................................... 32
x x
6. Chapter 05: Complementary and Alternative Therapies ........................................... 35
x x x x x
2|Pag
x x x x
e
x
, TEST BANK FOR PHARMACOLOGY 10TH EDITION BY MCCUISTION
x x x x x x x
7. Chapter 06: Pediatric Considerations ........................................................................40
x x x
8. Chapter 07: Geriatric Considerations.........................................................................47
x x x
9. Chapter 08: Drugs of Abuse .......................................................................................53
x x x x
10. Chapter 09: Safety and Quality...............................................................................59
x x x x
11. Chapter 10: Drug Administration ...........................................................................65
x x x
12. Chapter 11: Drug Calculations ...............................................................................70
x x x
13. Chapter 12: Fluid Volume and Electrolytes ............................................................75
x x x x x
14. Chapter 13: Vitamin and Mineral Replacement ......................................................84
x x x x x
15. Chapter 14: Nutritional Support .............................................................................91
x x x
16. Chapter 15: Adrenergic Agonists and Antagonists.................................................99
x x x x x
17. Chapter 16: Cholinergic Agonists and Antagonists..............................................105
x x x x x
18. Chapter 17: Stimulants ......................................................................................... 111
x x
19. Chapter 18: Depressants ....................................................................................... 115
x x
20. Chapter 19: Antiseizure Drugs .............................................................................121
x x x
21. Chapter 20: Drugs for Parkinson Disease and Alzheimer Disease .......................128
x x x x x x x x
22. Chapter 21: Drugs for Neuromuscular Disorders and Muscle Spasms ................134
x x x x x x x x
23. Chapter 22: Antipsychotics and Anxiolytics ........................................................140
x x x x
24. Chapter 23: Antidepressants and Mood Stabilizers ..............................................147
x x x x x
25. Chapter 24: Antiinflammatories ...........................................................................154
x x
26. Chapter 25: Analgesics .........................................................................................161
x x
27. Chapter 26: Antibacterials ....................................................................................168
x x
28. Chapter 27: Antituberculars, Antifungals, and Antivirals ....................................184
x x x x x
29. Chapter 28: Peptides, Antimalarials, and Anthelmintics ......................................192
x x x x x
30. Chapter 29: HIV- and AIDS-Related Drugs.........................................................195
x x x x x
31. Chapter 30: Transplant Drugs ...............................................................................199
x x x
32. Chapter 31: Vaccines............................................................................................202
x x
33. Chapter 32: Anticancer Drugs ..............................................................................206
x x x
34. Chapter 33: Targeted Therapies to Treat Cancer...................................................210
x x x x x x
35. Chapter 34: Biologic Response Modifiers ............................................................213
x x x x
36. Chapter 35: Upper Respiratory Disorders ............................................................217
x x x x
37. Chapter 36: Lower Respiratory Disorders ............................................................221
x x x x
38. Chapter 37: Cardiac Glycosides, Antianginals, and Antidysrhythmics .................227
x x x x x x
39. Chapter 38: Diuretics............................................................................................234
x x
40. Chapter 39: Antihypertensives .............................................................................238
x x
41. Chapter 40: Anticoagulants, Antiplatelets, and Thrombolytics ............................244
x x x x x
3|Pag
x x x x
e
x
, TEST BANK FOR PHARMACOLOGY 10TH EDITION BY MCCUISTION
x x x x x x x
42. Chapter 41: Antihyperlipidemics and Peripheral Vasodilators ............................251
x x x x x
43. Chapter 42: Gastrointestinal Tract Disorders .......................................................256
x x x x
44. Chapter 43: Antiulcer Drugs ................................................................................262
x x x
45. Chapter 44: Eye and Ear Disorders.......................................................................268
x x x x x
46. Chapter 45: Dermatologic Disorders ....................................................................272
x x x
47. Chapter 46: Pituitary, Thyroid, Parathyroid, and Adrenal Disorders ...................277
x x x x x x x
48. Chapter 47: Antidiabetics .....................................................................................284
x x
49. Chapter 48: Urinary Disorders .............................................................................290
x x x
50. Chapter 49: Pregnancy and Preterm Labor ...........................................................295
x x x x x
51. Chapter 50: Labor, Delivery, and Postpartum .......................................................301
x x x x x
52. Chapter 51: Neonatal and Newborn .....................................................................306
x x x x
53. Chapter 52: Women’s Reproductive Health ..........................................................308
x x x x
54. Chapter 53: Men’s Reproductive Health ..............................................................314
x x x x
55. Chapter 54: Sexually Transmitted Infections .......................................................318
x x x x
56. Chapter 55: Adult and Pediatric Emergency Drugs..............................................321
x x x x x x
1. Chapter 01: The Nursing Process and Patient-Centered Care
x x x x x x x
x McCuistion: Pharmacology: A Patient-Centered Nursing Process Approach, 10th
x x x x x x x
x Edition
MULTIPLE CHOICE x
1. The nursing process is a five-step decision-making approach that includes all of the following
x x x x x x x x x x x x x
steps, EXCEPT:
x x
a. Assessment
b. Patient problem
x
4|Pag
x x x x
e
x
, TEST BANK FOR PHARMACOLOGY 10TH EDITION BY MCCUISTION x x x x x x x
c. Planning
d. Right Drug x
ANS: D x
The nursing process is a five-step decision-making approach that includes: 1) assessment, 2)
x x x x x x x x x x x x
patient problem, 3) planning, 4) implementation, and 5) evaluation. “Right drug” is one of the
x x x x x x x x x x x x x x x
“Six Rights” of medication administration.
x x x x x
DIF: Cognitive Level: Understanding (Comprehension) x x x TOP: Nursing Process: x x
Planning MSC: NCLEX: Management of Care
x x x x x x
2. The nurse is using data collected to set goals or expected outcomes and interventions that
x x x x x x x x x x x x x x
x address the patient’s problems. Which step of the nursing process is the nurse applying?
x x x x x x x x x x x x x
a. Assessment
b. Patient problem x
c. Planning
d. Evaluation
ANS: C x
During the planning phase, the nurse uses the data collected to set goals or expected outcomes
x x x x x x x x x x x x x x x
and interventions which address the patient’s problems. The data was collected during the
x x x x x x x x x x x x x
“Assessment” and “Patient problem” steps. During the “Evaluation” phase the nurse would
x x x x x x x x x x x x
determine whether the goals and objectives set during the planning phase were met.
x x x x x x x x x x x x x
DIF: Cognitive Level: Understanding (Comprehension) x x x
TOP: Nursing Process: Nursing Intervention
x x x x x
MSC: NCLEX: Management of Care
x x x x
3. A 5-year-old child with type 1 diabetes mellitus has had repeated hospitalizations for episodes
x x x x x x x x x x x x x
of hyperglycemia. The parents tell the nurse that they can’t keep track of everything that has
x x x x x x x x x x x x x x x x
to be done to care for their child. The nurse reviews medications, diet, and symptom
x x x x x x x x x x x x x x x
management with the parents and draws up a daily checklist for the family to use. These
x x x x x x x x x x x x x x x x
activities are completed in which step of the nursing process?
x x x x x x x x x x
a. Assessment
b. Planning
c. Implementation
d. Evaluation
ANS: C x
5|Pag x x x x
e
x
